Autolus Therapeutics PLC

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Autolus Therapeutics PLC had 130.93M in cash and cash equivalents.

Autolus Therapeutics PLC reported 410.94M in total liabilities as of the latest reported quarter, including 73.44M in current liabilities and 337.50M in non-current liabilities.

As of the latest reported quarter, Autolus Therapeutics PLC's total assets were 589.07M, consisting of 435.92M in current assets and 153.15M in non-current assets.

Autolus Therapeutics PLC reported 178.13M in total shareholders' equity as of the latest reported quarter.